Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,784 | -4,004 | N/A | N/A | N/A |
| Depreciation Amortization | 13 | 6 | N/A | N/A | N/A |
| Accounts receivable | -8,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 14 | 4 | N/A | N/A | N/A |
| Other Working Capital | 389 | -69 | N/A | N/A | N/A |
| Other Operating Activity | 9,999 | 235 | 0 | 0 | 0 |
| Operating Cash Flow | $-4,369 | $-3,828 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,500 | 4,000 | N/A | N/A | N/A |
| Common Stock Issued | 70 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 8,954 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $11,524 | $4,000 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 658 | 486 | N/A | N/A | N/A |
| End Cash Position | 7,813 | 658 | N/A | N/A | N/A |
| Net Cash Flow | $7,155 | $172 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,369 | -3,828 | N/A | N/A | N/A |
| Free Cash Flow | -4,369 | -3,828 | 0 | 0 | 0 |